1 in 15 men. 1 in 18 women. Every year in the UK 43,000 people are newly diagnosed with colorectal cancer. Dr Anisha Patel is one of them. Young, fit, and married to a consultant gastroenterologist and bowel cancer screening specialist, in 2018 she was diagnosed with Stage 3 colorectal cancer. Despite being a family doctor, Anisha had no idea what would come next. With the benefit of hindsight, and after first-hand experience, she understands now that the diagnosis is just the beginning, that treatment can be physically and mentally overwhelming, and that the hard work really starts when the treatment ends. Drawing on her own experience and her medical expertise, as well as that of specialists in the field, Anisha's book is an essential companion for anyone facing a cancer diagnosis. She outlines what to expect at each stage, from diagnosis, through treatment and into the 'new normal' that awaits, with practical advice and emotional guidance for every step of the way. Hers is not the only voice; here you will find a chorus of individuals who share their own lived experiences of colorectal cancer and its aftermath, in the hope that they, too, can navigate you through the eye of the cancer storm, to thrive in the life beyond. Powerful and personal, this is a life-saving book for a life-changing diagnosis, and a testament to human resilience and the enduring power of hope.

Prostate cancer is the most common form of cancer (excluding skin cancer) among American men. In 1998 approximately 184,500 new cases of prostate cancer were diagnosed in the United States. However, if detected early, it is also among the most treatable forms of cancer, and due to advances in diagnosis and treatment, survival rates continue to rise. The five-year survival rate has increased from 50 percent in the period from 1960 to 1963 to 89 percent today. But most men--and their families--lack the most basic information about what to do when confronted with a diagnosis of prostate cancer. This book, written by internationally respected medical experts, sets out to explain everything a man needs to know. Written, updated, and revised under the auspices of the American Cancer Society, the nation's leader in cancer research, education, and rehabilitation, it contains the most up-to-date information about the disease. Even more, it is a patient's advocacy book, offering medical, practical, psychological, social, and emotional support. Through case histories and anecdotes--and always with compassion--it addresses the full range of issues that men with the disease may face.

In Mission in Bold Humili/ty, an international group of scholars explore and assess the life and work of David Bosch. In 1991 the publication of David Bosch's magnum opus, Transforming Mission: Paradigm Shifts in Theology of Mission, marked a high point in a long and distinguished career. Immediately acclaimed as one of the most significant texts on missiology in the past century, it was to be the scholar's last major publication due to Bosch's untimely death in 1992.In Mission in Bold Humility, editors Willem Saayman and Klippies Kritzinger, Bosch's longtime colleagues in the missiology faculty of the University of South Africa, gather appraisals of Bosch's work from a variety of theological perspectives and mission contexts. Together the distinguished authors offer invaluable critiques of Bosch's thought and insights into Transforming Mission. At the same time, Mission in Bold Humility assesses the significance of Bosch's many scholarly and humanitarian contributions: as a missiologist, as a man of the church, and as one who labored courageously on behalf of peace and justice in his native South Africa. Particularly notable is Frans J. Verstraelen's chapter on the influence of Africa in Bosch's thought, offering a penetrating analysis and criticism of an important facet of his life's work that is hardly known outside his native continent.Contributors: the editors, Dana L. Robert, Wilbert R. Shenk, Chritopher Sugden, Gerald H. Anderson, John S. Pobee, William R. Burrows, Jacob Kavunkal, Margaret E. Guider, Frans J. Verstraelen, Curt Cadorette, and Emilio Castro.

Yellow was her favorite color growing up on the farm. The color of corn. The color in their wedding. It was her husband's favorite "golf shirt color." It was the color of the 13 foot sunflowers they grew in their garden with their young daughters. Years later, a rare cancer diagnosis - "sarcoma"-- changed a lot in her life. Surgery. Chemotherapies. Lung surgery. Yet it turns out yellow is the "color for sarcoma"-- and sunflowers are the "flower." Tall, strong, and always looking toward the sun, Laura uses her faith, gratitude, prayer and the support of family and friends to help her through the first three years of living with sarcoma. She finds there is hope on the journey. This book is a compellation of Laura's "posts" from the Carepage.com journaling she has done through the first years of her illness. Originally thinking that she was writing to inform the congregation she co-pastored of her treatment, she found that she learned through writing as well. Insights are found in everyday things - gardens and baking and re-discovering knitting and quilting - and the extreme circumstances of her medical care, the challenges of facing disability, and severe pain starting at age 49. However, all are instances for discovering the Spirit at work in her life whether in times of lament or joy.Laura, her daughters, and family are familiar with cancer, as her husband died about six years before from Stage 4 colon cancer. Unlike colon cancer, sarcomas are very rare, and do not run in families. One out of every 100 cancers are sarcomas - of which there are almost 150 types. Laura learns that she has sclerosing epitheloid fibrosarcoma, an even more rare sub-type of sarcoma. Sarcomas are infrequently studied and have few available successful treatments. Hopeful treatment horizons stem from collaborative work of sarcoma researchers and learning more about the genetic mutations of sarcoma cells.The proceeds of this book are all going to fund sarcoma research at the University of Iowa Holden Comprehensive Cancer Center.

What should a Doctor be? A tribute to the medical profession, The Doctor Gene offers a collection of stories from the journey of the author, Dr. Rajas Deshpande, pursuing his medical career from deep inside rural India, all the way to an advanced Canadian university. In this heartfelt memoir, Deshpande narrates the inside story- what a doctor thinks and feels when interacting with a wide range of patients, the thrills of saving lives, and solving health puzzles every day. He also untangles the intricate mysteries of both the positive and the dark sides of human behaviour encountered while treating patients and interacting with their families. From strokes, epilepsy, and dementia, to AIDS, heart disease, and suicide, The Doctor Gene talks about situations from a patients as well as a doctors point of view. While still genuinely caring for the patient, todays doctor ?nds it di?cult to interact naturally and make decisions- simple and critical- under the perpetual shadow of medico-legal threats. Deshpande also addresses many such issues faced by the medical world, discussing their possible solutions. The Doctor Gene provides a deep insight into the noble medical profession, highlights the immense importance of a healthy doctor-patient relationship, and confesses how some patients teach doctors about life, love, and sacri?ce.

Part of the bestselling What Your Doctor May Not Tell You series, an informative, detailed guide to colorectal cancer, including treatment and prevention. Over 50,000 men and women die from colorectal cancer each year - a particularly alarming statistic since it is also one of the most preventable and treatable cancers. In fact, it is estimated that over one-third of colorectal cancer deaths could have been avoided. Now, there's hope. This book contains important information on beating colorectal cancer, including the six biggest lifestyle threats, the three nutritional supplements anyone at risk should take, the optimal timeframe for screenings, the pros and cons of new detection tests, and how to effectively treat cancerous and pre-cancerous polyps with both traditional and alternative methods.